In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...
An RNA interference therapy, targeting ANGPTL3 in the liver, drastically reduced fasting triglycerides in people with mixed hyperlipidemia, the ARCHES-2 trial showed. Used atop usual statins and other ...
A healthier heart and a healthier you begin with making lifestyle changes to lower triglycerides. Some triglycerides are important for good health, but too many can lead to heart disease & stroke.